AG˹ٷ

STOCK TITAN

[8-K] Avalon GloboCare Corp. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

PSQ Holdings, Inc. (PSQH) filed a Form 4 indicating that Chief Financial Officer and Director James Rinn received an equity award on 11-Jul-2025. The transaction involves 250,000 restricted stock units (RSUs) issued under the company’s 2023 Stock Incentive Plan. Each RSU entitles the holder to one share of Class A common stock upon vesting. The award is structured to vest in three equal annual tranches beginning 1-Jun-2025 and continuing through 1-Jun-2027. The filing shows no cash consideration (exercise price $0), confirming the grant is part of compensation rather than a market purchase or sale. Following the grant, Rinn holds 250,000 derivative securities directly, with no changes reported in non-derivative share ownership. No additional insider transactions or amendments appear in the document.

PSQ Holdings, Inc. (PSQH) ha presentato un modulo Form 4 che indica che il Chief Financial Officer e Direttore James Rinn ha ricevuto un premio in azioni il 11 luglio 2025. La transazione riguarda 250.000 unità di azioni vincolate (RSU) emesse nell’ambito del Piano di Incentivi Azionari 2023 della società. Ogni RSU dà diritto al possessore a una azione ordinaria di Classe A al momento della maturazione. Il premio è strutturato per maturare in tre tranche annuali uguali a partire dal 1° giugno 2025 fino al 1° giugno 2027. Il modulo indica che non è stata prevista alcuna controprestazione in denaro (prezzo di esercizio $0), confermando che la concessione fa parte della retribuzione e non di un acquisto o vendita sul mercato. Dopo la concessione, Rinn detiene direttamente 250.000 titoli derivati, senza variazioni nella proprietà di azioni non derivate. Nel documento non sono presenti ulteriori operazioni interne o modifiche.

PSQ Holdings, Inc. (PSQH) presentó un Formulario 4 que indica que el Director Financiero y Director James Rinn recibió una concesión de acciones el 11 de julio de 2025. La transacción involucra 250,000 unidades de acciones restringidas (RSU) emitidas bajo el Plan de Incentivos de Acciones 2023 de la compañía. Cada RSU otorga al titular una acción común Clase A al momento de la consolidación. La concesión está estructurada para consolidarse en tres partes iguales anuales desde el 1 de junio de 2025 hasta el 1 de junio de 2027. La presentación no muestra ninguna contraprestación en efectivo (precio de ejercicio $0), confirmando que la concesión es parte de la compensación y no una compra o venta en el mercado. Tras la concesión, Rinn posee directamente 250,000 valores derivados, sin cambios reportados en la propiedad de acciones no derivadas. No aparecen transacciones internas adicionales ni enmiendas en el documento.

PSQ Holdings, Inc. (PSQH)� 2025� 7� 11일에 최고재무책임� � 이사 James Rinn� 주식 보상� 받았음을 나타내는 Form 4� 제출했습니다. 이번 거래� 회사� 2023� 주식 인센티브 플랜� 따라 발행� 250,000개의 제한 주식 단위(RSU)와 관련되� 있습니다. � RSU� 권리 행사 � Class A 보통� 1주를 받을 � 있습니다. � 보상은 2025� 6� 1일부� 2027� 6� 1일까지 3년간 매년 동일� 비율� 분할하여 권리가 확정됩니�. 제출 서류에는 현금 대가가 없으�(행사가� $0), 이는 보상� 시장 거래가 아닌 보수� 일부임을 확인시켜 줍니�. 보상 이후 Rinn은 파생 증권 250,000주를 직접 보유하고 있으�, 비파� 주식 보유에는 변동이 없습니다. 문서에는 추가 내부� 거래� 수정 사항� 없습니다.

PSQ Holdings, Inc. (PSQH) a déposé un formulaire 4 indiquant que le Directeur financier et administrateur James Rinn a reçu une attribution d’actions le 11 juillet 2025. La transaction concerne 250 000 unités d’actions restreintes (RSU) émises dans le cadre du Plan d’incitation en actions 2023 de la société. Chaque RSU donne droit à une action ordinaire de classe A lors de son acquisition. L’attribution est structurée pour s’acquérir en trois tranches annuelles égales à partir du 1er juin 2025 jusqu’au 1er juin 2027. Le dépôt ne mentionne aucune contrepartie en espèces (prix d’exercice 0 $), confirmant que cette attribution fait partie de la rémunération et non d’un achat ou d’une vente sur le marché. Suite à cette attribution, M. Rinn détient directement 250 000 titres dérivés, sans changement dans la détention d’actions non dérivées. Aucun autre mouvement d’initié ou modification n’apparaît dans le document.

PSQ Holdings, Inc. (PSQH) hat ein Formular 4 eingereicht, das angibt, dass der Finanzvorstand und Direktor James Rinn am 11. Juli 2025 eine Aktienzuteilung erhalten hat. Die Transaktion umfasst 250.000 beschränkte Aktieneinheiten (RSUs), die im Rahmen des Aktienanreizplans 2023 des Unternehmens ausgegeben wurden. Jede RSU berechtigt den Inhaber beim Erwerb zum Bezug einer Aktie der Klasse A Stammaktien. Die Zuteilung ist so strukturiert, dass sie in drei gleichen jährlichen Tranchen vom 1. Juni 2025 bis zum 1. Juni 2027 vestet. Die Einreichung zeigt keine Barzahlung (Ausübungspreis 0 $), was bestätigt, dass die Gewährung Teil der Vergütung und kein Marktgeschäft ist. Nach der Zuteilung hält Rinn direkt 250.000 derivative Wertpapiere, ohne Änderungen im Besitz nicht-derivativer Aktien. Im Dokument sind keine weiteren Insider-Transaktionen oder Änderungen vermerkt.

Positive
  • Incentive alignment: A multi-year RSU package links the CFO’s compensation to share performance, encouraging shareholder-friendly decision-making.
Negative
  • Potential dilution: Conversion of 250,000 RSUs into common shares over three years will slightly expand the share count.

Insights

TL;DR: 250k RSU grant to PSQH CFO; aligns incentives, causes modest future dilution; overall neutral impact.

The Form 4 reveals a material but routine compensation award: 250,000 RSUs to CFO/Director James Rinn. Because each unit converts 1-for-1 into Class A shares, the grant could incrementally increase the outstanding share count over three years, exerting slight dilution. However, multi-year vesting ties management wealth to long-term share performance, which investors often view positively. The absence of open-market buying or selling suggests no immediate signaling on valuation. Given the lack of financial metrics or operational updates, the disclosure is not likely to move the stock materially and is best classified as neutral for valuation purposes.

PSQ Holdings, Inc. (PSQH) ha presentato un modulo Form 4 che indica che il Chief Financial Officer e Direttore James Rinn ha ricevuto un premio in azioni il 11 luglio 2025. La transazione riguarda 250.000 unità di azioni vincolate (RSU) emesse nell’ambito del Piano di Incentivi Azionari 2023 della società. Ogni RSU dà diritto al possessore a una azione ordinaria di Classe A al momento della maturazione. Il premio è strutturato per maturare in tre tranche annuali uguali a partire dal 1° giugno 2025 fino al 1° giugno 2027. Il modulo indica che non è stata prevista alcuna controprestazione in denaro (prezzo di esercizio $0), confermando che la concessione fa parte della retribuzione e non di un acquisto o vendita sul mercato. Dopo la concessione, Rinn detiene direttamente 250.000 titoli derivati, senza variazioni nella proprietà di azioni non derivate. Nel documento non sono presenti ulteriori operazioni interne o modifiche.

PSQ Holdings, Inc. (PSQH) presentó un Formulario 4 que indica que el Director Financiero y Director James Rinn recibió una concesión de acciones el 11 de julio de 2025. La transacción involucra 250,000 unidades de acciones restringidas (RSU) emitidas bajo el Plan de Incentivos de Acciones 2023 de la compañía. Cada RSU otorga al titular una acción común Clase A al momento de la consolidación. La concesión está estructurada para consolidarse en tres partes iguales anuales desde el 1 de junio de 2025 hasta el 1 de junio de 2027. La presentación no muestra ninguna contraprestación en efectivo (precio de ejercicio $0), confirmando que la concesión es parte de la compensación y no una compra o venta en el mercado. Tras la concesión, Rinn posee directamente 250,000 valores derivados, sin cambios reportados en la propiedad de acciones no derivadas. No aparecen transacciones internas adicionales ni enmiendas en el documento.

PSQ Holdings, Inc. (PSQH)� 2025� 7� 11일에 최고재무책임� � 이사 James Rinn� 주식 보상� 받았음을 나타내는 Form 4� 제출했습니다. 이번 거래� 회사� 2023� 주식 인센티브 플랜� 따라 발행� 250,000개의 제한 주식 단위(RSU)와 관련되� 있습니다. � RSU� 권리 행사 � Class A 보통� 1주를 받을 � 있습니다. � 보상은 2025� 6� 1일부� 2027� 6� 1일까지 3년간 매년 동일� 비율� 분할하여 권리가 확정됩니�. 제출 서류에는 현금 대가가 없으�(행사가� $0), 이는 보상� 시장 거래가 아닌 보수� 일부임을 확인시켜 줍니�. 보상 이후 Rinn은 파생 증권 250,000주를 직접 보유하고 있으�, 비파� 주식 보유에는 변동이 없습니다. 문서에는 추가 내부� 거래� 수정 사항� 없습니다.

PSQ Holdings, Inc. (PSQH) a déposé un formulaire 4 indiquant que le Directeur financier et administrateur James Rinn a reçu une attribution d’actions le 11 juillet 2025. La transaction concerne 250 000 unités d’actions restreintes (RSU) émises dans le cadre du Plan d’incitation en actions 2023 de la société. Chaque RSU donne droit à une action ordinaire de classe A lors de son acquisition. L’attribution est structurée pour s’acquérir en trois tranches annuelles égales à partir du 1er juin 2025 jusqu’au 1er juin 2027. Le dépôt ne mentionne aucune contrepartie en espèces (prix d’exercice 0 $), confirmant que cette attribution fait partie de la rémunération et non d’un achat ou d’une vente sur le marché. Suite à cette attribution, M. Rinn détient directement 250 000 titres dérivés, sans changement dans la détention d’actions non dérivées. Aucun autre mouvement d’initié ou modification n’apparaît dans le document.

PSQ Holdings, Inc. (PSQH) hat ein Formular 4 eingereicht, das angibt, dass der Finanzvorstand und Direktor James Rinn am 11. Juli 2025 eine Aktienzuteilung erhalten hat. Die Transaktion umfasst 250.000 beschränkte Aktieneinheiten (RSUs), die im Rahmen des Aktienanreizplans 2023 des Unternehmens ausgegeben wurden. Jede RSU berechtigt den Inhaber beim Erwerb zum Bezug einer Aktie der Klasse A Stammaktien. Die Zuteilung ist so strukturiert, dass sie in drei gleichen jährlichen Tranchen vom 1. Juni 2025 bis zum 1. Juni 2027 vestet. Die Einreichung zeigt keine Barzahlung (Ausübungspreis 0 $), was bestätigt, dass die Gewährung Teil der Vergütung und kein Marktgeschäft ist. Nach der Zuteilung hält Rinn direkt 250.000 derivative Wertpapiere, ohne Änderungen im Besitz nicht-derivativer Aktien. Im Dokument sind keine weiteren Insider-Transaktionen oder Änderungen vermerkt.

false 0001630212 0001630212 2025-07-14 2025-07-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): July 14, 2025

 

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38728   47-1685128

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification Number)

 

4400 Route 9 South, Suite 3100, Freehold, NJ 07728

(Address of principal executive offices)

 

(732) 780-4400

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   ALBT   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On July 14, 2025, the Company issued a press release announcing that the Company was granted a standard patent by the Hong Kong Intellectual Property Department with respect to its CAR-T and CAR-Natural Killer (NK) cell technology.

 

The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information included in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth under this Item 7.01 shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.

 

Item 9.01. Financial Statement and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press release of the Company dated July 14, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AVALON GLOBOCARE CORP.  
     
Dated: July 14, 2025 By: /s/ Luisa Ingargiola
  Name: Luisa Ingargiola
  Title: Chief Financial Officer

 

2

 

FAQ

What did PSQH disclose in its 14-Jul-2025 Form 4 filing?

The company reported granting 250,000 RSUs to CFO and Director James Rinn on 11-Jul-2025.

How many restricted stock units were awarded to PSQH CFO James Rinn?

He received 250,000 RSUs under the 2023 Stock Incentive Plan.

When do the RSUs granted to the PSQH CFO vest?

They vest in three equal annual installments starting 1-Jun-2025, completing on 1-Jun-2027.

Did the filing report any open-market purchases or sales by the insider?

No. The Form 4 shows only a compensation-based RSU grant with no share purchases or sales.

How could the RSU grant affect existing PSQH shareholders?

Upon vesting, the RSUs will create modest share dilution, but they also align the CFO’s incentives with shareholder value.
Avalon Globocare Corp

NASDAQ:ALBT

ALBT Rankings

ALBT Latest News

ALBT Latest SEC Filings

ALBT Stock Data

4.84M
2.48M
37.47%
1.52%
4.15%
AG˹ٷ Estate Services
Services-computer Programming Services
United States
FREEHOLD